期刊
EXPERT REVIEW OF VACCINES
卷 11, 期 6, 页码 733-744出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/ERV.12.35
关键词
adjuvant; adjuvant mechanisms; adjuvant systems; data mining; lipid A; liposomes; monophosphoryl lipid A; patents and intellectual property; peptide vaccines
类别
资金
- Henry M Jackson Foundation for the Advancement of Military Medicine [W81XWH-07-2-067]
- US Army Medical Research and Materiel Command [W81XWH-07-2-067]
Liposomes containing monophosphoryl lipid A (MPLA) have previously exhibited considerable potency and safety in human trials with a variety of candidate vaccines, including vaccines to malaria, HIV-1 and several different types of cancer. The long history of research and development of MPLA and liposomal MPLA as vaccine adjuvants reveals that there are numerous opportunities for creation and development of generic (nonproprietary) adjuvant system formulations with these materials that are not only highly potent and safe, but also readily available as native materials or as synthetic compounds. They are easily manufactured as potentially inexpensive and easy to use adjuvant systems and might be effective even with synthetic peptides as antigens.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据